# Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)

> **NCT05141383** · NA · COMPLETED · sponsor: **Institut Curie** · enrollment: 80 (actual)

## Conditions studied

- Prostate Cancer
- Healthy Donors

## Interventions

- **OTHER:** Urine sampling

## Key facts

- **NCT ID:** NCT05141383
- **Lead sponsor:** Institut Curie
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-05-04
- **Primary completion:** 2024-09-03
- **Final completion:** 2024-09-03
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2025-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05141383

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05141383, "Comparative Study of Diagnostic and Prognosis Biomarkers of Prostate Cancer in Liquid Biopsy (HOPE)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05141383. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*